Circadian System and Glucose Metabolism: Implications for Physiology and Disease

Trends in Endocrinology and Metabolism

Volumn 27, Issue 5, 2016, Pages 282-293

  Qian, Jingyi ^a,b   Scheer, Frank A J L ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Circadian rhythms; Food timing; Glucose metabolism; Melatonin; Sleep; Type 2 diabetes

Indexed keywords

TRANSCRIPTION FACTOR ARNTL; GLUCOSE; MELATONIN;

BEHAVIOR; CIRCADIAN RHYTHM; ENVIRONMENTAL CHANGE; FOOD INTAKE; GENE DELETION; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; INSULIN RESPONSE; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SLEEP WAKING CYCLE; ANIMAL; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SLEEP;

ANIMALS; CIRCADIAN RHYTHM; DIABETES MELLITUS, TYPE 2; GLUCOSE; HUMANS; MELATONIN; SLEEP;

EID: 84962855296     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2016.03.005     Document Type: Review

References (100)

1. Chen L., et al. The worldwide epidemiology of type 2 diabetes mellitus - present and future perspectives. Nat. Rev. Endocrinol. 2012, 8:228-236.
2. Haus E., Smolensky M. Biological clocks and shift work: circadian dysregulation and potential long-term effects. Cancer Causes Control 2006, 17:489-500.
3. Navara K.J., Nelson R.J. The dark side of light at night: physiological, epidemiological, and ecological consequences. J. Pineal Res. 2007, 43:215-224.
4. Unhealthy sleep-related behaviors - 12 states, 2009. MMWR Morb. Mortal. Wkly. Rep. 2011, 60:233-266. Centers for Disease Control and Prevention.
5. Roenneberg T., et al. Social jetlag and obesity. Curr. Biol. 2012, 22:939-943.
6. Mattson M.P., et al. Meal frequency and timing in health and disease. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:16647-16653.
7. Smolensky M.H., et al. Nocturnal light pollution and underexposure to daytime sunlight: complementary mechanisms of circadian disruption and related diseases. Chronobiol. Int. 2015, 32:1029-1048.
8. Wong P.M., et al. Social jetlag, chronotype, and cardiometabolic risk. J. Clin. Endocrinol. Metab. 2015, 100:4612-4620.
9. Fonken L.K., Nelson R.J. The effects of light at night on circadian clocks and metabolism. Endocr. Rev. 2014, 35:648-670.
10. Wang X.S., et al. Shift work and chronic disease: the epidemiological evidence. Occup. Med. 2011, 61:78-89.
11. Suwazono Y., et al. Shiftwork and impaired glucose metabolism: a 14-year cohort study on 7104 male workers. Chronobiol. Int. 2009, 26:926-941.
12. Pan A., et al. Rotating night shift work and risk of type 2 diabetes: two prospective cohort studies in women. PLoS Med. 2011, 8:e1001141.
13. Merikanto I., et al. Associations of chronotype and sleep with cardiovascular diseases and type 2 diabetes. Chronobiol. Int. 2013, 30:470-477.
14. Reutrakul S., et al. The relationship between breakfast skipping, chronotype, and glycemic control in type 2 diabetes. Chronobiol. Int. 2014, 31:64-71.
15. Parsons M.J., et al. Social jetlag, obesity and metabolic disorder: investigation in a cohort study. Int. J. Obes. (Lond.) 2015, 39:842-848.
16. Nedeltcheva A.V., Scheer F.A. Metabolic effects of sleep disruption, links to obesity and diabetes. Curr. Opin. Endocrinol. Diab. Obes. 2014, 21:293-298.
17. Morris C.J., et al. The impact of the circadian timing system on cardiovascular and metabolic function. Prog. Brain Res. 2012, 199:337-358.
18. Van Cauter E., et al. Roles of circadian rhythmicity and sleep in human glucose regulation. Endocr. Rev. 1997, 18:716-738.
19. la Fleur S.E., et al. A daily rhythm in glucose tolerance: a role for the suprachiasmatic nucleus. Diabetes 2001, 50:1237-1243.
20. Clore J.N., et al. Sleep-associated fall in glucose disposal and hepatic glucose output in normal humans. Putative signaling mechanism linking peripheral and hepatic events. Diabetes 1989, 38:285-290.
21. Bolli G.B., et al. Demonstration of a dawn phenomenon in normal human volunteers. Diabetes 1984, 33:1150-1153.
22. Radziuk J., Pye S. Diurnal rhythm in endogenous glucose production is a major contributor to fasting hyperglycaemia in type 2 diabetes. Suprachiasmatic deficit or limit cycle behaviour?. Diabetologia 2006, 49:1619-1628.
23. Saad A., et al. Diurnal pattern to insulin secretion and insulin action in healthy individuals. Diabetes 2012, 61:2691-2700.
24. Sheard N.F., et al. Dietary carbohydrate (amount and type) in the prevention and management of diabetes: a statement by the American Diabetes Association. Diabetes Care 2004, 27:2266-2271.
25. Colberg S.R., et al. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary. Diabetes Care 2010, 33:2692-2696.
26. Van Cauter E., et al. Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep. J. Clin. Invest. 1991, 88:934-942.
27. Duffy J.F., Dijk D.J. Getting through to circadian oscillators: why use constant routines?. J. Biol. Rhythms 2002, 17:4-13.
28. Shea S.A., et al. Independent circadian and sleep/wake regulation of adipokines and glucose in humans. J. Clin. Endocrinol. Metab. 2005, 90:2537-2544.
29. Scheer F.A., et al. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:4453-4458.
30. Van Cauter E., et al. Circadian modulation of glucose and insulin responses to meals: relationship to cortisol rhythm. Am. J. Physiol. 1992, 262:E467-E475.
31. Morris C.J., et al. Endogenous circadian system and circadian misalignment impact glucose tolerance via separate mechanisms in humans. Proc. Natl. Acad. Sci. U.S.A. 2015, 112:E2225-E2234.
32. Kalsbeek A., Strubbe J.H. Circadian control of insulin secretion is independent of the temporal distribution of feeding. Physiol. Behav. 1998, 63:553-558.
33. Morris C.J., et al. Circadian system, sleep and endocrinology. Mol. Cell. Endocrinol. 2012, 349:91-104.
34. Lamia K.A., et al. Physiological significance of a peripheral tissue circadian clock. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:15172-15177.
35. Jacobi D., et al. Hepatic Bmal1 regulates rhythmic mitochondrial dynamics and promotes metabolic fitness. Cell Metab. 2015, 22:709-720.
36. Marcheva B., et al. Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature 2010, 466:627-631.
37. Lee J., et al. Loss of Bmal1 leads to uncoupling and impaired glucose-stimulated insulin secretion in beta-cells. Islets 2011, 3:381-388.
38. Rakshit K., et al. Bmal1 is required for beta cell compensatory expansion, survival and metabolic adaptation to diet-induced obesity in mice. Diabetologia 2016, 59:734-743.
39. Dyar K.A., et al. Muscle insulin sensitivity and glucose metabolism are controlled by the intrinsic muscle clock. Mol. Metab. 2014, 3:29-41.
40. Hodge B.A., et al. The endogenous molecular clock orchestrates the temporal separation of substrate metabolism in skeletal muscle. Skelet. Muscle 2015, 5:17.
41. Paschos G.K., et al. Obesity in mice with adipocyte-specific deletion of clock component Arntl. Nat. Med. 2012, 18:1768-1777.
42. Yang G., et al. Timing of expression of the core clock gene Bmal1 influences its effects on aging and survival. Sci. Transl. Med. 2016, 8:324ra16.
43. Zhang E.E., et al. Cryptochrome mediates circadian regulation of cAMP signaling and hepatic gluconeogenesis. Nat. Med. 2010, 16:1152-1156.
44. Seron-Ferre M., et al. Circadian rhythms in the fetus. Mol. Cell. Endocrinol. 2012, 349:68-75.
45. Leproult R., et al. Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss. Diabetes 2014, 63:1860-1869.
46. Fonken L.K., et al. Light at night increases body mass by shifting the time of food intake. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:18664-18669.
47. Qian J., et al. Circadian disruption and diet-induced obesity synergize to promote development of beta cell failure and diabetes in male rats. Endocrinology 2015, 156:4426-4436.
48. Qian J., et al. Consequences of exposure to light at night on the pancreatic islet circadian clock and function in rats. Diabetes 2013, 62:3469-3478.
49. Gale J.E., et al. Disruption of circadian rhythms accelerates development of diabetes through pancreatic beta-cell loss and dysfunction. J. Biol. Rhythms 2011, 26:423-433.
50. Coomans C.P., et al. Detrimental effects of constant light exposure and high-fat diet on circadian energy metabolism and insulin sensitivity. FASEB J. 2013, 27:1721-1732.
51. Gil-Lozano M., et al. Short-term sleep deprivation with nocturnal light exposure alters time-dependent glucagon-like peptide-1 and insulin secretion in male volunteers. Am. J. Physiol. Endocrinol. Metab. 2016, 310:E41-E50.
52. Buxton O.M., et al. Adverse metabolic consequences in humans of prolonged sleep restriction combined with circadian disruption. Sci. Transl. Med. 2012, 4:129ra43.
53. Morris C.J., et al. Effects of the internal circadian system and circadian misalignment on glucose tolerance in chronic shift workers. J. Clin. Endocrinol. Metab. 2016, 101:1066-1074.
54. Broussard J.L., et al. Impaired insulin signaling in human adipocytes after experimental sleep restriction: a randomized, crossover study. Ann. Intern. Med. 2012, 157:549-557.
55. Stamatakis K.A., Punjabi N.M. Effects of sleep fragmentation on glucose metabolism in normal subjects. Chest 2010, 137:95-101.
56. Nonogaki K. New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia 2000, 43:533-549.
57. Rizza R.A., et al. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. J. Clin. Endocrinol. Metab. 1982, 54:131-138.
58. Markwald R.R., et al. Impact of insufficient sleep on total daily energy expenditure, food intake, and weight gain. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:5695-5700.
59. Calvin A.D., et al. Effects of experimental sleep restriction on caloric intake and activity energy expenditure. Chest 2013, 144:79-86.
60. Tasali E., et al. Slow-wave sleep and the risk of type 2 diabetes in humans. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:1044-1049.
61. Borbely A.A., et al. The two-process model of sleep regulation: a reappraisal. J. Sleep Res. 2016, Published online January 14, 2016. 10.1111/jsr.12371.
62. Dijk D.J., Czeisler C.A. Paradoxical timing of the circadian rhythm of sleep propensity serves to consolidate sleep and wakefulness in humans. Neurosci. Lett. 1994, 166:63-68.
63. Gonnissen H.K., et al. Sleep architecture when sleeping at an unusual circadian time and associations with insulin sensitivity. PLoS ONE 2013, 8:e72877.
64. Curie T., et al. In vivo imaging of the central and peripheral effects of sleep deprivation and suprachiasmatic nuclei lesion on PERIOD-2 protein in mice. Sleep 2015, 38:1381-1394.
65. Mongrain V., et al. Sleep loss reduces the DNA-binding of BMAL1, CLOCK, and NPAS2 to specific clock genes in the mouse cerebral cortex. PLoS ONE 2011, 6:e26622.
66. Eckel R.H., et al. Morning circadian misalignment during short sleep duration impacts insulin sensitivity. Curr. Biol. 2015, 25:3004-3010.
67. Moller-Levet C.S., et al. Effects of insufficient sleep on circadian rhythmicity and expression amplitude of the human blood transcriptome. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:E1132-E1141.
68. Wang J.B., et al. Timing of energy intake during the day is associated with the risk of obesity in adults. J. Hum. Nutr. Diet. 2014, 27(Suppl. 2):255-262.
69. Garaulet M., et al. Timing of food intake predicts weight loss effectiveness. Int. J. Obes. (Lond.) 2013, 37:604-611.
70. Arble D.M., et al. Circadian timing of food intake contributes to weight gain. Obesity 2009, 17:2100-2102.
71. Nakajima K., Suwa K. Association of hyperglycemia in a general Japanese population with late-night-dinner eating alone, but not breakfast skipping alone. J. Diab. Metab. Disord. 2015, 14:16.
72. Morgan L.M., et al. Effect of meal timing and glycaemic index on glucose control and insulin secretion in healthy volunteers. Br. J. Nutr. 2012, 108:1286-1291.
73. Bandin C., et al. Meal timing affects glucose tolerance, substrate oxidation and circadian-related variables: a randomized, crossover trial. Int. J. Obes. (Lond.) 2015, 39:828-833.
74. Damiola F., et al. Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus. Genes Dev. 2000, 14:2950-2961.
75. Sato M., et al. The role of the endocrine system in feeding-induced tissue-specific circadian entrainment. Cell Rep. 2014, 8:393-401.
76. Ando H., et al. Indirect effects of glucagon-like peptide-1 receptor agonist exendin-4 on the peripheral circadian clocks in mice. PLoS ONE 2013, 8:e81119.
77. Landgraf D., et al. Oxyntomodulin regulates resetting of the liver circadian clock by food. Elife 2015, 4:e06253.
78. Boivin D.B., James F.O. Light treatment and circadian adaptation to shift work. Ind. Health 2005, 43:34-48.
79. Vetter C., et al. Aligning work and circadian time in shift workers improves sleep and reduces circadian disruption. Curr. Biol. 2015, 25:907-911.
80. Salgado-Delgado R., et al. Food intake during the normal activity phase prevents obesity and circadian desynchrony in a rat model of night work. Endocrinology 2010, 151:1019-1029.
81. Lyssenko V., et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat. Genet. 2009, 41:82-88.
82. Bonnefond A., et al. Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat. Genet. 2012, 44:297-301.
83. Gaulton K.J., et al. Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nat. Genet. 2015, 47:1415-1425.
84. Costes S., et al. Activation of melatonin signaling promotes beta-cell survival and function. Mol. Endocrinol. 2015, 29:682-692.
85. Rubio-Sastre P., et al. Acute melatonin administration in humans impairs glucose tolerance in both the morning and evening. Sleep 2014, 37:1715-1719.
86. Sartori C., et al. Melatonin improves glucose homeostasis and endothelial vascular function in high-fat diet-fed insulin-resistant mice. Endocrinology 2009, 150:5311-5317.
87. She M., et al. Piromelatine, a novel melatonin receptor agonist, stabilizes metabolic profiles and ameliorates insulin resistance in chronic sleep restricted rats. Eur. J. Pharmacol. 2014, 727:60-65.
88. Ramracheya R.D., et al. Function and expression of melatonin receptors on human pancreatic islets. J. Pineal Res. 2008, 44:273-279.
89. Chen Z., et al. Small molecule modifiers of circadian clocks. Cell. Mol. Life Sci. 2013, 70:2985-2998.
90. Jagannath A., et al. The CRTC1-SIK1 pathway regulates entrainment of the circadian clock. Cell 2013, 154:1100-1111.
91. Ruiter M., et al. Hormones and the autonomic nervous system are involved in suprachiasmatic nucleus modulation of glucose homeostasis. Curr. Diabetes Rev. 2006, 2:213-226.
92. Morris C.J., et al. Circadian misalignment increases cardiovascular disease risk factors in humans. Proc. Natl. Acad. Sci. U.S.A. 2016, 113:E1402-E1411.
93. Partch C.L., et al. Molecular architecture of the mammalian circadian clock. Trends Cell Biol. 2014, 24:90-99.
94. Koike N., et al. Transcriptional architecture and chromatin landscape of the core circadian clock in mammals. Science 2012, 338:349-354.
95. Peschke E., et al. Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status. J. Pineal Res. 2006, 40:135-143.
96. Hu K., et al. Noninvasive fractal biomarker of clock neurotransmitter disturbance in humans with dementia. Sci. Rep. 2013, 3:2229.
97. Mohawk J.A., et al. Central and peripheral circadian clocks in mammals. Annu. Rev. Neurosci. 2012, 35:445-462.
98. Gallego M., Virshup D.M. Post-translational modifications regulate the ticking of the circadian clock. Nat. Rev. Mol. Cell Biol. 2007, 8:139-148.
99. Lowrey P.L., Takahashi J.S. Mammalian circadian biology: elucidating genome-wide levels of temporal organization. Annu. Rev. Genomics Hum. Genet. 2004, 5:407-441.
100. Garaulet M., et al. Common type 2 diabetes risk variant in MTNR1B worsens the deleterious effect of melatonin on glucose tolerance in humans. Metabolism 2015, 64:1650-1657.